Profile Previews

Get a glimpse into our company and investor data—powered by the PitchBook Platform

Geneticure

Geneticure
2014 FOUNDED
PRIVATE STATUS
Early Stage VC LATEST DEAL TYPE
$850K LATEST DEAL AMOUNT
6 INVESTORS
Description

Developer of pharmacogenomic tests designed to help predict treatment methods for large chronic and dangerous diseases. The company's pharmacogenomic tests uses multi-gene, disease specific genomic panels, supported by clinical evidence that helps doctors and clinicians create personalized and patient-specific treatments for controlling high blood pressure and hypertension, enabling them to personalize therapy based on the specific patient and reduce treatment time.

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Biotechnology
Other Industries
Other Pharmaceuticals and Biotechnology
Decision/Risk Analysis
Primary Office
  • 4 3rd Street South West
  • Suite B
  • Rochester, MN 55902
  • United States

+1 (952) 000-0000
Request full access to PitchBook

You’re viewing a free company profile from the PitchBook Platform. To explore Geneticure’s full profile, request a free trial.

Geneticure Valuation and Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Early Stage VC 17-Aug-2017 $850K 00.000 Completed Startup
4. Angel (individual) 18-Oct-2016 00000 00.000 Completed Pre-Clinical Trials
3. Grant 25-Sep-2016 0000 00000 Completed Pre-Clinical Trials
2. Accelerator/Incubator $186K Completed Pre-Clinical Trials
1. Angel (individual) 15-Aug-2014 $186K $186K Completed Product In Beta Test
To view this company’s complete deal history including valuation and funding, request access »

Geneticure Competitors (11)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pathway Genomics Venture Capital-Backed San Diego, CA 000 00000 00000000000 00000
0000000 0000000 00 Formerly Angel backed Charleston, SC 00 00.000 0000000000.
000000 00000000 Corporation Salt Lake City, UT 0000 00000 000000 - 000 00000
0000000 Corporation Seattle, WA 00
00000000 Venture Capital-Backed King of Prussia, PA 00 000.00 0000000000 0 000.00
To view this company’s complete list of competitors, request access »

Geneticure Investors (6)

Investor Name Investor Type Holding Investor Since Participating Rounds Board
Seat
Contact
Info
M25 Venture Capital Minority 000 0000 000000 0
Wireframe Ventures Venture Capital Minority 000 0000 000000 0
ImpactAssets Impact Investing Minority 000 0000 000000 0
Stanford Graduate School of Business Other Minority 000 0000 000000 0
Carlson School of Management University 000 0000 000000 0
You’re viewing 5 of 6 investors. Get the full list »

Geneticure Executive Team (7)

Name Title Board
Seat
Contact
Info
Scott Snyder Co-Founder, President & Chief Executive Officer
Eric Snyder Ph.D Co-Founder & Chief Operating Officer
Ryan Sprissler Ph.D Co-Founder & Chief Scientific Officer
Thomas Olson Ph.D Chief Clinical Officer
David Herbert Executive Vice President of Strategy

1 Former Executive

You’re viewing 5 of 7 executives. Get the full list »